2004
DOI: 10.1016/j.ehj.2004.05.004
|View full text |Cite|
|
Sign up to set email alerts
|

Association of hypo-responsive toll-like receptor 4 variants with risk of myocardial infarction*1

Abstract: The association found between TLR4 genotype and risk of MI suggests that TLR4 genetic variants could potentially affect the susceptibility to MI and that TLR4-mediated innate immunity is implicated in the pathogenesis of MI.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
83
1
7

Year Published

2004
2004
2010
2010

Publication Types

Select...
5
2
2

Relationship

0
9

Authors

Journals

citations
Cited by 149 publications
(94 citation statements)
references
References 29 publications
3
83
1
7
Order By: Relevance
“…9 In addition, several candidate gene studies have been conducted, testing variants in genes involved in inflammation, for example, CD14, TLR4 and VCAM1, for association with atherosclerosis and significant associations have been reported by some groups. 10,11 Notably, the majority of these studies were conducted in European populations and the results could not be replicated in Chinese Han populations. This suggests that there are substantial differences in the genetic contributors to CAD between these populations.…”
Section: Introductionmentioning
confidence: 99%
“…9 In addition, several candidate gene studies have been conducted, testing variants in genes involved in inflammation, for example, CD14, TLR4 and VCAM1, for association with atherosclerosis and significant associations have been reported by some groups. 10,11 Notably, the majority of these studies were conducted in European populations and the results could not be replicated in Chinese Han populations. This suggests that there are substantial differences in the genetic contributors to CAD between these populations.…”
Section: Introductionmentioning
confidence: 99%
“…However, population-based studies designed to determine the impact of TLR4 polymorphism on the risk of myocardial infarction (MI) are so far inconclusive, and the data seem conflicting. Some studies suggest that individuals with the single nucleotide polymorphism of TLR4 Asp299Gly, who have an impaired host immune response toward LPS stimulation, have a lower risk of MI (9,15,54), whereas others suggest an increased (32) or the same level of risk (83) of MI in the polymorphism compared with the control population. In animal models of ischemic cardiac injury, the role of TLRs is incompletely defined.…”
mentioning
confidence: 99%
“…However, a larger study using myocardial infarction as a hard end point arrived at a different conclusion. 30 The 299Gly and 399Ile were significantly more common among 1213 survivors of a first myocardial infarction than in a matched control group of 1561 individuals in the Stockholm Heart Epidemiology Program (SHEEP). The reason for this discrepancy is unknown; one may speculate that TLR4-dependent activation of the AP-1 and NF-B pathways promote smooth muscle proliferation and the formation of a stable fibrous cap.…”
Section: See Pages 1213 and 1220mentioning
confidence: 99%
“…The reason for this discrepancy is unknown; one may speculate that TLR4-dependent activation of the AP-1 and NF-B pathways promote smooth muscle proliferation and the formation of a stable fibrous cap. 30 In the Dutch REGRESS study of myocardial infarction, 299Gly carriers had more severe coronary disease and gained more from statin treatment than those carrying the wild-type allele. 31 At balance, the clinical studies of TLR4 polymorphism suggest that (1) TLR4 activation promotes lesion growth; (2) it reduces the risk for myocardial infarction, possibly by promoting plaque stabilization; and (3) the TLR4 pathway interacts with statins.…”
Section: See Pages 1213 and 1220mentioning
confidence: 99%